牛熊異動 | 阿里牛證飆漲100%
港股阿里巴巴高開近4%,突破230港元關口,截至發稿,阿里巴巴漲3.22%,報231港元,阿里匯豐一甲牛E漲超100%。
【通過日內融買入1手阿里巴巴,僅需佔用本金2300港元】
近日中信證券發表研報稱,儘管國家統計局數據顯示12月季度電商大盤偏弱,但預計阿里核心商業仍有望保持良好的增長韌性、客戶管理收入有望實現相對穩健增長。同時預計公司對淘寶特價版等新產品投入仍將持續,佈局長期;預計雲業務EBITA margin將保持優化趨勢,有望在2021財年內實現季度盈利。因此看好公司在商業與科技領域的競爭力與中長期價值,中長期保持樂觀態度,維持公司“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.